The 20 references in paper L. Yakovleva P., Ye. Matyakin G., M. Kropotov A., N. Blokhin N., Л. Яковлева П., Е. Матякин Г., М. Кропотов А., И. Романов С. (2015) “ОБЩИЕ АСПЕКТЫ ДИАГНОСТИКИ И ЛЕЧЕНИЯ МЕСТНО-РАСПРОСТРАНЕННОГО РАКА ЩИТОВИДНОЙ ЖЕЛЕЗЫ // GENERAL ASPECTS OF THE DIAGNOSIS AND TREATMENT OF LOCALLY ADVANCED THYROID CANCER” / spz:neicon:ogsh:y:2013:i:2:p:10-20

1
Avenia N., Monacelli M., Sanguenetti A. et al. Therapeutic options in locally advanced thyroid carcinoma. Our experience. Аnn Ital Chir 2012;Nov–Dec;83(6):481–5.
(check this in PDF content)
2
AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. Endocr Pract 2001;7(3):175–7.
(check this in PDF content)
3
Чиссов В.И., Старинский В.В. Состояние онкологической помощи населению в России в 1999 году. М.: Ранко-пресс, 2000. 176 с.
(check this in PDF content)
4
Валдина Е.А. Заболевания щитовидной железы. М.: Медицина, 1993. С. 53–58.
(check this in PDF content)
5
Пачес А.И., Пропп Р.М. Рак щитовидной железы. М.: Медицина, 1995. С. 83–85.
(check this in PDF content)
6
Shaha A.R., Shah J.P. Recurrent Differentiated Thyroid Cancer. Endocrin Pract 2012 Jul;11:1–11.
(check this in PDF content)
7
Ontal K.I., Straehley C.J. The surgical treatment of well-differentiated carcinoma of the thyroid. Amer Surg 1985;3(11):146–51.
(check this in PDF content)
8
Vickery L. Jr, Wang C.A., Walker A.M. Treatment of intrathyroidal papillary carcinoma of the thyroid. Cancer 1987; 60(11):2587–95.
(check this in PDF content)
9
Черников Р.А., Бабунов А.Ф., Фельдшеро в И.М. Отдаленные результаты лечения папиллярного рака щитовидной железы. Материалы III тиреоидо логического конгресса. М., 2004. С. 312.
(check this in PDF content)
10
Ishichara T., Kukichi K., Ikeda T. Resection of thyroid carcinoma with infiltration of the trachea. Thorax 1978;33:204–10.
(check this in PDF content)
11
Hopkins C.R., Reading C.C. Thyroid and parathyroid imaging. Semin Ultrasound CT MR 1995;16(4);279–95.
(check this in PDF content)
12
Meer S.G., Schreinemakers J.M., Zelissen P.M. et al. Fine-needle aspiration of thyroid tumors: identifying factors associated with adequacy rate in a large academic center in the Netherlands. Diagn Cytopathol 2012 May;40 Suppl 1:E21–6.
(check this in PDF content)
13
Серебров В.Т. Топографическая анатомия. Томск, 1961. С. 121.
(check this in PDF content)
14
Lee Yoon Se et al. Clinical implications of bilateral lateral cervical lymph node metastasis in papillary thyroid cancer: a risk factor for lung metastasis. Ann Surg Oncol 2011;18(12):3486–92.
(check this in PDF content)
15
Leboulleux S., Bastholt L., Krause T. et al. Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomized, double-blind, phase 2 trial. Lancet Oncol 2012 Sep;13(9):897–905.
(check this in PDF content)
16
Frampton J.E. Vandetanib: in medullary thyroid cancer. Drugs 2012 Jul 9;72(10):1423–36.
(check this in PDF content)
17
Degrauwe N., Sosa J.A., Roman S., Deshpande H.A. Vandetanib for the treatment of metastatic medullary thyroid cancer. Clin Med Insights Oncol 2012;6:243–52.
(check this in PDF content)
18
Smit J. Treatment of advanced medullary thyroid cancer. Thyroid Res 2013 Mar 14;6 Suppl 1:S7.
(check this in PDF content)
19
Grabowski P., Briest F., Baum R.P. et al. Vandetanib therapy in medullary thyroid cancer. Drugs Today (Barc) 2012 Nov; 48(11):723–33.
(check this in PDF content)
20
Wu X., Jin Y., Cui I.H. et al. Addition of vandetanib to chemotherapy in advanced solid cancers: a meta-analysis. Anticancer Drugs 2012 Aug;23(7):731–8.
(check this in PDF content)